Cargando…
Interleukin-6 and the determinants of severe COVID-19: A retrospective cohort study
Cytokines, notably interleukin-6 (IL-6), increase considerably in patients with severe corona virus disease 2019 (COVID-19). This vigorous immune response may cause end-organ failure or death; hence, measuring IL-6 in the context of patient characteristics may help predict outcomes and encourage ear...
Autores principales: | Hafez, Wael, Nasa, Prashant, Khairy, Ahmed, Jose, Mohan, Abdelshakour, Mahmoud, Ahmed, Sabah, Abdulaal, Fatema, Nair, Nivedita, Ahmad, Mohammad, Rashid, Vanya Jalal, Ayman, Youmna, John, Steffi, Fdl Alla, Osman, Abu Shady, Reham, Mohamed, Ahmed Ali, Soliman, Rami, Nader, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637408/ https://www.ncbi.nlm.nih.gov/pubmed/37960722 http://dx.doi.org/10.1097/MD.0000000000036037 |
Ejemplares similares
-
Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020) -
Multiplex PCR: Aid to more-timely and directed therapeutic intervention for patients with infectious gastroenteritis
por: Montasser, Karim, et al.
Publicado: (2022) -
Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity
por: Younossi, Zobair M., et al.
Publicado: (2017) -
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020) -
Long-term sequelae of COVID-19 (myalgic encephalomyelitis): An international cross-sectional study
por: Shaheen, Nour, et al.
Publicado: (2022)